FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049123886> ?p ?o ?g. }

• W3049123886 endingPage "1825" @default.
• W3049123886 startingPage "1818" @default.
• W3049123886 abstract "Purpose The updated World Health Organization guidelines recommend efavirenz (EFV) 400 mg as the preferred alternate first-line antiretroviral therapy to dolutegravir, with EFV 600 mg recommended only in special situations. We examined the pharmacokinetic (PK) properties of EFV 600 mg/d during pregnancy and post partum to inform EFV dosing decisions in pregnant women. Methods Ghanaian pregnant women with HIV infection initiating tenofovir disoproxil fumarate 300 mg/lamivudine 300 mg/EFV 600 mg fixed-dose combination tablet once daily were enrolled. Efavirenz concentrations were measured at 4 weeks of antiretroviral therapy initiation during pregnancy and 6 weeks post partum using validated LC-MS/MS assays. Efavirenz PK parameters were calculated using noncompartmental analysis, and within-group parameters between the 2 periods were compared. Findings Of 25 enrolled women, 19 completed PK sampling during pregnancy and post partum. The Cmax, Cmin, AUC0–24h, and CL/F for EFV during pregnancy were similar to values at 6 weeks post partum. The pregnancy/postpartum geometric mean ratios for EFV Cmax, Cmin, AUC0–24, and CL/F were 1.10 (95% CI, 0.93–1.31), 0.88 (95% CI, 0.67–1.17), 0.84 (95% CI, 0.71–0.98), and 1.20 (95% CI, 1.02–1.40), respectively. Viral load suppression (HIV RNA <200 copies/mL) was achieved in 16 of 17 participants (94%) by the time of delivery. There was 1 maternal-to-child transmission. Implications We found that the PK parameters of EFV 600 mg once daily during pregnancy were similar to those in the postpartum period. Our findings suggest that EFV dose adjustment during pregnancy is not necessary in our study population." @default.
• W3049123886 created "2020-08-21" @default.
• W3049123886 creator A5007987317 @default.
• W3049123886 creator A5032085827 @default.
• W3049123886 creator A5037456762 @default.
• W3049123886 creator A5037684823 @default.
• W3049123886 creator A5047784782 @default.
• W3049123886 creator A5052451681 @default.
• W3049123886 creator A5055231042 @default.
• W3049123886 creator A5059101690 @default.
• W3049123886 creator A5062092186 @default.
• W3049123886 creator A5062647561 @default.
• W3049123886 creator A5086177629 @default.
• W3049123886 creator A5087207218 @default.
• W3049123886 creator A5090200063 @default.
• W3049123886 date "2020-09-01" @default.
• W3049123886 modified "2023-10-17" @default.
• W3049123886 title "Pharmacokinetics of Efavirenz 600 mg Once Daily During Pregnancy and Post Partum in Ghanaian Women Living With HIV" @default.
• W3049123886 cites W1607895158 @default.
• W3049123886 cites W1988442464 @default.
• W3049123886 cites W1992870356 @default.
• W3049123886 cites W2012459259 @default.
• W3049123886 cites W2050781209 @default.
• W3049123886 cites W2071086973 @default.
• W3049123886 cites W2100993118 @default.
• W3049123886 cites W2110885633 @default.
• W3049123886 cites W2118283332 @default.
• W3049123886 cites W2159601567 @default.
• W3049123886 cites W2184719281 @default.
• W3049123886 cites W2794281539 @default.
• W3049123886 cites W2904966271 @default.
• W3049123886 doi "https://doi.org/10.1016/j.clinthera.2020.07.008" @default.
• W3049123886 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7578077" @default.
• W3049123886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32811669" @default.
• W3049123886 hasPublicationYear "2020" @default.
• W3049123886 type Work @default.
• W3049123886 sameAs 3049123886 @default.
• W3049123886 citedByCount "3" @default.
• W3049123886 countsByYear W30491238862023 @default.
• W3049123886 crossrefType "journal-article" @default.
• W3049123886 hasAuthorship W3049123886A5007987317 @default.
• W3049123886 hasAuthorship W3049123886A5032085827 @default.
• W3049123886 hasAuthorship W3049123886A5037456762 @default.
• W3049123886 hasAuthorship W3049123886A5037684823 @default.
• W3049123886 hasAuthorship W3049123886A5047784782 @default.
• W3049123886 hasAuthorship W3049123886A5052451681 @default.
• W3049123886 hasAuthorship W3049123886A5055231042 @default.
• W3049123886 hasAuthorship W3049123886A5059101690 @default.
• W3049123886 hasAuthorship W3049123886A5062092186 @default.
• W3049123886 hasAuthorship W3049123886A5062647561 @default.
• W3049123886 hasAuthorship W3049123886A5086177629 @default.
• W3049123886 hasAuthorship W3049123886A5087207218 @default.
• W3049123886 hasAuthorship W3049123886A5090200063 @default.
• W3049123886 hasBestOaLocation W30491238862 @default.
• W3049123886 hasConcept C112705442 @default.
• W3049123886 hasConcept C131872663 @default.
• W3049123886 hasConcept C142462285 @default.
• W3049123886 hasConcept C159047783 @default.
• W3049123886 hasConcept C22979827 @default.
• W3049123886 hasConcept C2777288759 @default.
• W3049123886 hasConcept C2778335254 @default.
• W3049123886 hasConcept C2779234561 @default.
• W3049123886 hasConcept C2779502633 @default.
• W3049123886 hasConcept C2781432083 @default.
• W3049123886 hasConcept C2993143319 @default.
• W3049123886 hasConcept C3013748606 @default.
• W3049123886 hasConcept C3018745865 @default.
• W3049123886 hasConcept C54355233 @default.
• W3049123886 hasConcept C71924100 @default.
• W3049123886 hasConcept C86803240 @default.
• W3049123886 hasConcept C98274493 @default.
• W3049123886 hasConceptScore W3049123886C112705442 @default.
• W3049123886 hasConceptScore W3049123886C131872663 @default.
• W3049123886 hasConceptScore W3049123886C142462285 @default.
• W3049123886 hasConceptScore W3049123886C159047783 @default.
• W3049123886 hasConceptScore W3049123886C22979827 @default.
• W3049123886 hasConceptScore W3049123886C2777288759 @default.
• W3049123886 hasConceptScore W3049123886C2778335254 @default.
• W3049123886 hasConceptScore W3049123886C2779234561 @default.
• W3049123886 hasConceptScore W3049123886C2779502633 @default.
• W3049123886 hasConceptScore W3049123886C2781432083 @default.
• W3049123886 hasConceptScore W3049123886C2993143319 @default.
• W3049123886 hasConceptScore W3049123886C3013748606 @default.
• W3049123886 hasConceptScore W3049123886C3018745865 @default.
• W3049123886 hasConceptScore W3049123886C54355233 @default.
• W3049123886 hasConceptScore W3049123886C71924100 @default.
• W3049123886 hasConceptScore W3049123886C86803240 @default.
• W3049123886 hasConceptScore W3049123886C98274493 @default.
• W3049123886 hasFunder F4320332480 @default.
• W3049123886 hasFunder F4320337355 @default.
• W3049123886 hasFunder F4320337611 @default.
• W3049123886 hasIssue "9" @default.
• W3049123886 hasLocation W30491238861 @default.
• W3049123886 hasLocation W30491238862 @default.
• W3049123886 hasOpenAccess W3049123886 @default.
• W3049123886 hasPrimaryLocation W30491238861 @default.
• W3049123886 hasRelatedWork W1999842374 @default.
• W3049123886 hasRelatedWork W2046934157 @default.

• next